CalciMedica, Inc. Common Stock (CALC NASDAQ) stock market data APIs
$2.0059
-0.3(-15%)
as of July 11, 2025
Try our APIs with
free plan!
CalciMedica, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company's lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. It also develops Auxora for the treatment of acute ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory indications. The company is based in La Jolla, California.
Prev. Close
2.0059
Open
1.7065
High
2.2593
Low
1.6828
52 wk Range
1.42-5.97
Market Cap
27 944 K
Shares Outstanding
13 972 K
EPS
-0.36
Beta
1.248
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CalciMedica, Inc. Common Stock data using free add-ons & libraries
Get CalciMedica, Inc. Common Stock Fundamental Data
CalciMedica, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA: -24 876 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-14
- EPS/Forecast: -1.47
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CalciMedica, Inc. Common Stock News
New
Catalyst Watch: Bank earnings rush, OPEC report, Tesla EVs get Grok, and Superman at the box office
[Wall Street sign in Lower Manhattan, NYC] georgeclerk Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that...
Thursday's Insider Activity: Top Buys and Sells in US Stocks
This article summarizes the most significant insider buys and sells reported on Thursday, July 10, 2025, for US stocks. Top Insider Buys: CalciMedica, Inc. (NASDAQ:CALC) saw director Eric W. Roberts...
Calcimedica (CALC) director Roberts buys $8k in shares
Eric W. Roberts, a director at CalciMedica, Inc. (NASDAQ:CALC), has recently purchased 5,000 shares of common stock at $1.6047 per share, close to the current trading price of $1.62. The total value o...
CalciMedica chief scientific officer Stauderman buys $1,850 in stock
Kenneth A. Stauderman, Chief Scientific Officer of CalciMedica, Inc. (NASDAQ:CALC), recently purchased 1,000 shares of common stock. The transaction, which occurred on July 1, 2025, involved the acqui...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
